BLOK:LSE:LSE-First Trust Indxx Innovative Transaction & Process UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 3025.75

Change

-56.25 (-1.83)%

Market Cap

N/A

Volume

607.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 636.56B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 259.48B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing BLOK:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.74% 65% D 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.74% 64% D 61% D-
Trailing 12 Months  
Capital Gain 13.15% 87% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.15% 86% B+ 78% C+
Trailing 5 Years  
Capital Gain 106.34% 78% C+ 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 106.34% 76% C+ 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 12.15% 71% C- 73% C
Dividend Return 12.15% 70% C- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.64% 55% F 72% C
Risk Adjusted Return 96.07% 86% B+ 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike